ALEXANDRIA, Va., June 16 -- United States Patent no. 12,305,169, issued on May 20, was assigned to National University Corporation Tokyo Medical and Dental University (Tokyo).

"BBB-crossing lipid ligand of hetero nucleic acid" was invented by Takanori Yokota (Tokyo), Tetsuya Nagata (Tokyo), Hideki Furukawa (Kanagawa, Japan), Yasuo Nakagawa (Kanagawa, Japan), Takatoshi Yogo (Kanagawa, Japan), Ryosuke Tokunoh (Kanagawa, Japan), Shigekazu Sasaki (Kanagawa, Japan), Kosuke Hidaka (Kanagawa, Japan), Tomohiro Seki (Kanagawa, Japan), Kenichi Miyata (Kanagawa, Japan), Yusuke Adachi (Kanagawa, Japan) and Naoto Arimura (Kanagawa, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The object of the present invention i...